Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Stratified cancer screening: the practicalities of implementation.

Dent T, Jbilou J, Rafi I, Segnan N, Törnberg S, Chowdhury S, Hall A, Lyratzopoulos G, Eeles R, Eccles D, Hallowell N, Pashayan N, Pharoah P, Burton H.

Public Health Genomics. 2013;16(3):94-9. doi: 10.1159/000345941. Epub 2013 Jan 26.

PMID:
23363703
2.

Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, Hall P, Pharoah P, Burton H.

Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14. Review.

3.

[Screening for cancer: what's new?].

Sasco AJ.

Bull Cancer. 2000 Mar;87(3):239-43. Review. French.

5.

The problems with risk selection; scientific and psychosocial aspects.

Hartman AR.

Recent Results Cancer Res. 2005;166:125-44. Review.

PMID:
15648188
6.

Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues.

Hall AE, Chowdhury S, Hallowell N, Pashayan N, Dent T, Pharoah P, Burton H.

J Public Health (Oxf). 2014 Jun;36(2):285-91. doi: 10.1093/pubmed/fdt078. Epub 2013 Aug 28. Review.

7.

Screening for cancer: when to stop?: A practical guide and review of the evidence.

Soung MC.

Med Clin North Am. 2015 Mar;99(2):249-62. doi: 10.1016/j.mcna.2014.11.002. Epub 2014 Dec 23. Review.

PMID:
25700582
9.

Screening for cancer: future potential.

Cuzick J.

Eur J Cancer. 1999 Dec;35(14):1925-32. Review.

PMID:
10711235
10.

Screening for Cervical, Prostate, and Breast Cancer: Interpreting the Evidence.

Carter SM, Williams J, Parker L, Pickles K, Jacklyn G, Rychetnik L, Barratt A.

Am J Prev Med. 2015 Aug;49(2):274-85. doi: 10.1016/j.amepre.2015.01.009. Epub 2015 Jun 16. Review.

PMID:
26091929
11.

Cancer screening in older adults in an era of genomics and longevity.

Greco K.

Semin Oncol Nurs. 2006 Feb;22(1):10-9. Review.

PMID:
16458178
12.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
13.

Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

PMID:
17319238
14.

Prostate cancer screening.

Tenke P, Horti J, Balint P, Kovacs B.

Recent Results Cancer Res. 2007;175:65-81. Review.

PMID:
17432554
15.

[Breast cancer screening different from that used for the general population: who is concerned and with which approach?].

Chappuis PO.

Rev Med Suisse. 2006 May 17;2(66):1296-8, 1301-2, 1304-5. Review. French.

PMID:
16775990
16.

Promoting cancer screening: Learning from experience.

Meissner HI, Smith RA, Rimer BK, Wilson KM, Rakowski W, Vernon SW, Briss PA.

Cancer. 2004 Sep 1;101(5 Suppl):1107-17. Review.

17.

Prostate cancer screening: clinical applications and challenges.

Brawley OW.

Urol Oncol. 2004 Jul-Aug;22(4):353-7. Review.

PMID:
15283896
18.
19.

Detection of latent prostate cancer from routine screening: comparison with breast cancer screening.

Benoit RM, Naslund MJ.

Urology. 1995 Oct;46(4):533-6; discussion 536-7. Review.

PMID:
7571223
20.

Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.

Etzioni R, Gulati R, Mallinger L, Mandelblatt J.

Ann Intern Med. 2013 Jun 4;158(11):831-8. doi: 10.7326/0003-4819-158-11-201306040-00008. Review.

Supplemental Content

Support Center